-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Announces Significant Reduction in Microglia Activation in PET Scan of Moderate Alzheimer's Patient Treated with Intranasal Foralumab
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Expands Phase 2 Clinical Trial for Non-Active Secondary Progressive Multiple Sclerosis to Additional Prestigious U.S. Medical Centers
-
-
-
-
-
-
-
Tiziana Life Sciences (TLSA) Receives $3.4 Million in Non-Dilutive Funding
-
474,823 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


